Mark Knapp

Dr. Mark Knapp is a Managing Director & Head of Institutional Sales at Jennings Capital, Inc. since September 2011.
Dr. Mark Knapp was Head of Institutional Sales & Trading at Pope & Co. Ltd. and a Principal at Pope & Co. from March 2010 to August 2011.
Prior to that, he was Director & Head of Institutional Equity Sales at Fraser Mackenzie Ltd. form November 2008 to February 2010 and Senior Biotechnology Equity Analyst at Clarus Securities from July 2007 to August 2008.
Before that, he worked as Director & Senior Biotech Analyst at Loewen, Ondaatje, McCutcheon May 2002 from June 2007.
Dr. Knapp received his B.Sc.
in Immunology from University of Toronto in 1993 and an M.Sc.
in Pharmacology from University of Toronto in 1997.
He also earned his MBA in Strategy & Finance form York University-Schulich School of Business in 2002 and Ph.D.
in Neuropharmacology form University of Toronto.